Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course

BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. MOGAD can present with a monophasic or relapsing disease course with distinct clinical manifestations.However, data on the disease course and...

Full description

Bibliographic Details
Main Authors: Ariel Rechtman, Livnat Brill, Omri Zveik, Benjamin Uliel, Nitzan Haham, Atira S. Bick, Netta Levin, Adi Vaknin-Dembinsky
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.867190/full